Cor Vasa 2018, 60(3):e246-e250 | DOI: 10.1016/j.crvasa.2017.08.005

Low cardiovascular event rate and high atrial fibrillation recurrence rate one year after electrical cardioversion

Evija Knokaa,b,*, Irina Pupkevicaa,b, Baiba Lurinaa,b, Ginta Kamzolaa,b, Aldis Strelnieksa,c, Oskars Kalejsa,b, Aivars Lejnieksa,c
a Riga Stradins University, Dzirciema street 16, Riga, LV-1007, Latvia
b Latvian Center of Cardiology, Pauls Stradins Clinical University Hospital, Pilsonu street 13, Riga, LV-1002, Latvia
c Riga East Clinical University hospital, Hipokrata street 2, Riga, LV-1038, Latvia

Background: Electrical cardioversion is widely used to restore sinus rhythm in patients with atrial fibrillation. However, the long term clinical event and sinus rhythm maintenance rates following electrical cardioversion still remains unclear. This study evaluated one year incidence and risk factors for cardiovascular events and atrial fibrillation recurrence in a single center clinical practice.

Methods: In a prospective study 188 patients with atrial fibrillation who underwent electrical cardioversion were enrolled. Patients and their primary care physicians were followed up one year after cardioversion and patient clinical and arrhythmic event rate was evaluated. Data obtained from patients and general practitioners were combined and the results were analyzed with PSPP 0.8.5. software.

Results: Electrical cardioversion success rate was 90.4%. Within a year after cardioversion one patient (0.6%) suffered myocardial infarction, three patients (1.9%) had a stroke/transitory ischemic attack (TIA), three patients (1.6%) died and three patients (1.9%) had a bleeding event that required hospitalization. The presence of diabetes mellitus was the only factor with a tendency to increase the risk of combined event of myocardial infarction, stroke/TIA and bleeding (p = 0.096). At follow up 30.0% of patients reported having atrial fibrillation and within a year 62.2% had suffered at least one atrial fibrillation paroxysm. The proportion of patients who underwent additional cardioversions after the initial hospitalization was 32.5%. The factors that significantly increased the risk of atrial fibrillation recurrence were history of stroke/TIA (p = 0.014) and increased left atrial volume index on echocardiography (p = 0.039). Greater left atrial diameter had a tendency towards an increased risk (p = 0.087).

Conclusions: Cardiovascular event rate one year after electrical cardioversion was low. Electrical cardioversion had a high immediate success rate, however, maintenance of stable sinus rhythm in the long term was low.

Keywords: Atrial fibrillation; Cardiovascular events; Electrical cardioversion

Received: April 20, 2017; Revised: August 28, 2017; Accepted: August 30, 2017; Published: June 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Knoka E, Pupkevica I, Lurina B, Kamzola G, Strelnieks A, Kalejs O, Lejnieks A. Low cardiovascular event rate and high atrial fibrillation recurrence rate one year after electrical cardioversion. Cor Vasa. 2018;60(3):e246-250. doi: 10.1016/j.crvasa.2017.08.005.
Download citation

References

  1. P. Kirchhof, S. Benussi, D. Kotecha, et al., 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC), European Heart Journal 37 (2016) 2893-2962. Go to original source... Go to PubMed...
  2. S. Colilla, A. Crow, W. Petkun, et al., Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population, American Journal of Cardiology 112 (2013) 1142-1147. Go to original source... Go to PubMed...
  3. Y. Miyasaka, M.E. Barnes, B.J. Gersh, et al., Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence, Circulation 114 (2006) 119-125. Go to original source... Go to PubMed...
  4. A. Sheikh, N.J. Patel, N. Nalluri, et al., Trends in hospitalization for atrial fibrillation: epidemiology, cost, and implications for the future, Progress in Cardiovascular Diseases 58 (2015) 105-116. Go to original source... Go to PubMed...
  5. P.A. Wolf, R.D. Abbott, W.B. Kannel, Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke 22 (1991) 983-988. Go to original source... Go to PubMed...
  6. M.J. Harrison, J. Marshall, Atrial fibrillation, TIAs and completed strokes, Stroke 15 (1984) 441-442. Go to original source... Go to PubMed...
  7. D.C. Anderson, L.J. Kappelle, M. Eliasziw, et al., Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosis, Stroke 33 (2002) 1963. Go to original source... Go to PubMed...
  8. A. Odutayo, C.X. Wong, A.J. Hsiao, et al., Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis, British Medical Journal 354 (2016) i4482. Go to original source... Go to PubMed...
  9. E. Anter, M. Jessup, D.J. Callans, Atrial fibrillation and heart failure, Circulation 119 (2009) 2516-2525. Go to original source... Go to PubMed...
  10. R.A. Vermont, B. Geelhoed, N. Verweij, et al., Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands, Journal of the American College of Cardiology 66 (2015) 1000-1007. Go to original source... Go to PubMed...
  11. S. Apostolakis, K.G. Haeusler, M. Oeff, et al., Low stroke risk after elective cardioversion of atrial fibrillation: an analysis of the Flec-SL trial, International Journal of Cardiology 168 (2013) 3977-3981. Go to original source... Go to PubMed...
  12. K.E. Airaksinen, T. Gronberg, I. Nuotio, et al., Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study, Journal of the American College of Cardiology 62 (2013) 1187-1192. Go to original source... Go to PubMed...
  13. D.G. Shin, I. Cho, B. Hartaigh, et al., Cardiovascular events of electrical cardioversion under optimal anticoagulation in atrial fibrillation: the multicenter analysis, Yonsei Medical Journal 56 (2015) 1552-1558. Go to original source... Go to PubMed...
  14. X. Yao, N.S. Abraham, G.C. Alexander, et al., Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation, Journal of the American Heart Association 5 (2016) e003074. Go to original source... Go to PubMed...
  15. I.C. Van Gelder, H.J. Crijns, W.H. Van Gilst, et al., Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter, American Journal of Cardiology 68 (1991) 41-46. Go to original source... Go to PubMed...
  16. B. Akdemir, R.E. Altekin, M. Kucuk, et al., The significance of the left atrial volume index in cardioversion success and its relationship with recurrence in patients with non-valvular atrial fibrillation subjected to electrical cardioversion: a study on diagnostic accuracy, Anadolu Kardiyoloji Dergisi 13 (2013) 18-25. Go to original source... Go to PubMed...
  17. M.H. Raitt, A.S. Volgman, R.G. Zoble, et al., AFFIRM Investigators. Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study, American Heart Journal 151 (2006) 390-396. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.